Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilde Vranckx

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Acta Clinica Belgica|July 1, 2021
Next generation sequencing in therapy-related myeloid neoplasms compared to <i>de novo</i> myeloid neoplasmsHelena Claerhout, Hilde Vranckx, Els Lierman, et al.
Annals of Hematology|February 9, 2011
CML with e6a2 BCR-ABL1 transcript: an aggressive entity?Karolien Anne Beel, Jan Lemmens, Hilde Vranckx, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 22, 2004
Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor siteBartosz Wasag, Maria Debiec-Rychter, Patrick Pauwels, et al.
Gastroenterology|February 3, 2005
Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutantsMaria Debiec-Rychter, Jan Cools, Herlinde Dumez, et al.
Nature Genetics|December 25, 2012
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemiaKim De Keersmaecker, Zeynep Kalender Atak, Ning Li, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Acta Clinica Belgica|July 1, 2021
Next generation sequencing in therapy-related myeloid neoplasms compared to <i>de novo</i> myeloid neoplasmsHelena Claerhout, Hilde Vranckx, Els Lierman, et al.
Annals of Hematology|February 9, 2011
CML with e6a2 BCR-ABL1 transcript: an aggressive entity?Karolien Anne Beel, Jan Lemmens, Hilde Vranckx, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 22, 2004
Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor siteBartosz Wasag, Maria Debiec-Rychter, Patrick Pauwels, et al.
Gastroenterology|February 3, 2005
Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutantsMaria Debiec-Rychter, Jan Cools, Herlinde Dumez, et al.
Nature Genetics|December 25, 2012
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemiaKim De Keersmaecker, Zeynep Kalender Atak, Ning Li, et al.
Pageof 1